AALBERTS NV 39.300 € (-0,41 %) 
BNP PARIBAS ACT.A 100.700 € (+0,88 %) ASML HOLDING 1 569.000 € (-2,11 %) LVMH 489.900 € (-0,62 %) INVENTIVA 3.730 € (0,00 %) SANOFI 76.230 € (-0,33 %) SCOR SE 31.880 € (+1,01 %) PHILIPS KON 24.060 € (+0,59 %) SCHNEIDER ELECTRIC 269.650 € (-0,13 %) AVANTIUM 7.090 € (+0,28 %) ARCADIS 34.520 € (+0,88 %) CARREFOUR 16.490 € (+0,95 %) AIRBUS 197.260 € (+0,38 %) PERNOD RICARD 64.200 € (+0,94 %) VINCI 119.000 € (-0,29 %) POUJOULAT 5.400 € (+0,37 %) CELLECTIS 2.590 € (-4,15 %) STMICROELECTRONICS 62.000 € (-1,08 %) FORVIA 9.082 € (+0,89 %) SMCP 5.170 € (-0,19 %) 2CRSI 30.700 € (-3,46 %) S.E.B. 46.640 € (-0,04 %) NANOBIOTIX 35.560 € (+4,28 %) ASM INTERNATIONAL 910.400 € (-1,77 %) PLANISWARE 20.550 € (+0,24 %) MAUREL ET PROM 7.785 € (-1,64 %) NEXITY 7.575 € (0,00 %) SOITEC 98.000 € (-5,86 %) THALES 223.300 € (-1,54 %) DBV TECHNOLOGIES 2.852 € (+0,07 %) CREDIT AGRICOLE 17.490 € (+0,37 %) SARTORIUS STED BIO 183.300 € (+2,06 %) 
MEXEDIA 3.630 € (-5,84 %) VOLTALIA 6.900 € (-2,13 %) CAPGEMINI 88.960 € (-0,04 %) MEDINCELL 27.100 € (-2,66 %) 
SES 7.705 € (-1,03 %) INPOST 15.470 € (+0,32 %) MAGNUM 16.308 € (+2,40 %) COMPAGNIE ODET 1 456.000 € (-0,41 %) ING GROEP N.V. 28.415 € (-0,05 %) DANONE 72.420 € (0,00 %) AIR LIQUIDE 174.300 € (+0,77 %) ORANGE 15.870 € (+0,03 %) GREEN EARTH GROUP 1.180 € (+3,06 %) LAKEFRONT BIOTHER. 26.320 € (-1,20 %) BENETEAU 6.070 € (-0,49 %) STREAMWIDE 71.000 € (-6,58 %) GETLINK SE 18.480 € (-0,65 %) NEXANS 134.000 € (+0,90 %) HEIJMANS KON 100.100 € (-4,03 %) KERLINK 1.165 € (-3,72 %) HIPAY GROUP 5.460 € (-2,15 %) CORBION 20.520 € (-0,39 %) CA TOULOUSE 31 CCI 128.000 € (-4,32 %) NACON 0.206 € (-2,83 %) NRJ GROUP 6.840 € (-0,58 %) CRCAM NORM.SEINE 162.500 € (-0,61 %) FUGRO 9.675 € (+0,52 %) TOMTOM 4.600 € (-0,22 %) |
21/04/2023 16:19
EQS-Adhoc: Aurubis AG exceeds market expectations for the second quarter 2022/23 and increases full-year forecastEQS-Ad-hoc: Aurubis AG / Key word(s): Half Year Results/Change in Forecast Aurubis AG exceeds market expectations for the second quarter 2022/23 and increases full-year forecast
Hamburg, April 21, 2023 – According to preliminary figures, Aurubis AG generated operating earnings before taxes (EBT) of € 166 million in Q2 of fiscal year 2022/23 (previous year: € 168 million)*, thus exceeding market expectations. Operating EBT for the first half of fiscal year 2022/23 amounts to € 291 million (previous year: € 331 million)*.
The main reasons for the very strong quarterly result were considerably increased treatment and refining charges for concentrates, a significantly higher Aurubis copper premium and very high demand for wire rod at higher prices. These positive effects more than offset the drop in sulfuric acid revenues.
As a result, Aurubis AG is also increasing its forecast for fiscal year 2022/23: The Aurubis Group now anticipates an operating EBT between € 450 and 550 million. The forecast range for operating EBT was previously between € 400 and 500 million.
According to preliminary calculations, IFRS consolidated earnings before taxes (EBT) in the first half of 2022/23 come to € 203 million (previous year: € 686 million). Q2 accounts for € 132 million of this amount (previous year: € 281 million).
The final results for the first half of fiscal year 2022/23 will be released on May 11, 2023.
*See definition of operating EBT adjustment on September 30, 2022 – detailed in 2022/23 Q1 Report, page 17.
End of Inside Information 21-Apr-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
1614273 21-Apr-2023 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière